Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
about
Etanercept-induced pityriasis lichenoides chronica in a patient with rheumatoid arthritis.TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapyNeurological adverse events associated with anti-tumor necrosis factor α treatment.Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.Safety of biologic therapy in rheumatoid arthritis.Morphea associated with the use of adalimumab: a case report and review of the literature.Etanercept provides an effective, safe and flexible short- and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence.TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®)).A Case Report of Majocchi's Granuloma Associated with Combined Therapy of Topical Steroids and AdalimumabDesensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent.Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa.Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
P2860
Q35144172-E2FB3A85-C32B-40E3-A3E8-BECCCC4E1B56Q36453770-926FD791-76D4-4995-98CD-DEE1B6FB229AQ36834202-C67D60AE-1C41-42C0-8A36-5E4FE5C56A78Q37760062-4AD29D76-EE07-4BBD-B7D1-704312EDA62EQ37831189-428A15A1-4955-4160-8660-24D10CDF1C2BQ37867162-1942EB7F-ABC3-418B-ABF8-07764F117F9AQ37944433-4D72C685-6037-4518-81A3-DC609FF51B5DQ37957758-E572EE9E-9895-4B97-85E7-BB3DB6C15E01Q38027577-34EA0BB0-E997-44A7-894C-CA54315ACD4DQ38125529-5B947D32-9360-4D25-AF47-C7E4FD9A9069Q38766862-5AAFCEF9-CFA1-491E-9832-667C65A15FE6Q38910179-2344E7A4-DDC9-40BB-82A9-5F899C783CA3Q40833894-DEE9C3AD-9A74-4B09-82BE-E6C5166BBE96Q42399453-50442957-1901-47CD-A433-2CBE6F1E36A0Q52668444-C332CD05-55A7-4226-AAD4-230E226228F7Q53228858-59EB6667-19A6-4507-A929-187F027CC65A
P2860
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@en
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@nl
type
label
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@en
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@nl
prefLabel
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@en
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@nl
P2093
P1476
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy.
@en
P2093
Andrés Navarro-Ruiz
Consuelo Borrás
Elvira Casterá
Joaquín Borrás-Blasco
P304
P356
10.1097/SMJ.0B013E3181BB554C
P407
P577
2009-11-01T00:00:00Z